Animalcare sees strategy results

The resolution of supply chain problems and the launch of several new products last year helped animal pharmaceutical specialist Animalcare (ANCR) return to sustained organic revenue growth during the half. The new management team has been in place since January and the challenge will be to apply higher value and more complex techniques to reformulating pharmaceuticals for treatment of pets so that the company can maintain its market niches.

To continue reading, register today

to enjoy limited access to the following:

  • Daily trading news
  • Funds coverage
  • Features on big investment themes
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now